OrthoPediatrics Statistics
OrthoPediatrics (2X7) Stock Statistics & Valuation Metrics
Total Valuation
OrthoPediatrics has a market cap or net worth of EUR 766.33M. The enterprise value is EUR 598.83M.
- Market Cap
- EUR 766.33M
- Enterprise Value
- EUR 598.83M
Share Statistics
OrthoPediatrics has 26,110,476 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 26,110,476
- Owned by Insiders
- 32.84%
- Owned by Institutions
- 43.87%
Financial Efficiency
OrthoPediatrics’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -6.27%.
- Return on Equity (ROE)
- -0.11
- Return on Assets (ROA)
- -0.08
- Return on Invested Capital (ROIC)
- -6.27%
- Return on Capital Employed (ROCE)
- -0.06
- Revenue Per Employee
- 392.60K
- Profits Per Employee
- -65.86K
- Employee Count
- 602
- Asset Turnover
- 0.46
- Inventory Turnover
- 0.48
Valuation Ratios
The current PE Ratio of OrthoPediatrics is -22.62. OrthoPediatrics’s PEG ratio is -0.73.
- PE Ratio
- -22.62
- PS Ratio
- 3.20
- PB Ratio
- 2.30
- Price to FCF
- 265.62
- Price to Operating Cash Flow
- 62.53
- PEG Ratio
- -0.73
Income Statement
In the last 12 months, OrthoPediatrics had revenue of 236.35M and earned -39.65M in profits. Earnings per share was -1.69.
- Revenue
- 236.35M
- Gross Profit
- 172.66M
- Operating Income
- -29.00M
- Pretax Income
- -39.19M
- Net Income
- -39.65M
- EBITDA
- -12.07M
- Earnings Per Share (EPS)
- -1.69
Cash Flow
In the last 12 months, operating cash flow was 12.49M and capital expenditures -9.31M, giving a free cash flow of 3.18M billion.
- Operating Cash Flow
- 12.49M
- Free Cash Flow
- 3.18M
- Free Cash Flow per Share
- 0.13
Dividends & Yields
OrthoPediatrics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.38%
- Earnings Yield
- -4.34%
Stock Price Statistics
- Beta
- 0.55
- 52-Week Price Change
- 100.00%
- 50-Day Moving Average
- 20.79
- 200-Day Moving Average
- 16.87
- Relative Strength Index (RSI)
- 68.65
- Average Volume (3m)
- 400
Important Dates
OrthoPediatrics upcoming earnings date is Mar 10, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 27, 2026
- Next Earnings Date
- Mar 10, 2027
- Ex-Dividend Date
- ―
Financial Position
OrthoPediatrics as a current ratio of 5.55, with Debt / Equity ratio of 28.85%
- Current Ratio
- 5.55
- Quick Ratio
- 2.65
- Debt to Market Cap
- 0.24
- Net Debt to EBITDA
- -6.66
- Interest Coverage Ratio
- -4.84
Taxes
In the past 12 months, OrthoPediatrics has paid 460.00K in taxes.
- Income Tax
- 460.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
OrthoPediatrics EV to EBITDA ratio is 380.56, with an EV/FCF ratio of 291.16.
- EV to Sales
- 3.51
- EV to EBITDA
- 380.56
- EV to Free Cash Flow
- 291.16
- EV to Operating Cash Flow
- 74.10
Balance Sheet
OrthoPediatrics has EUR 44.23M in cash and marketable securities with EUR 98.36M in debt, giving a net cash position of -EUR 54.13M billion.
- Cash & Marketable Securities
- EUR 44.23M
- Total Debt
- EUR 98.36M
- Net Cash
- -EUR 54.13M
- Net Cash Per Share
- -EUR 2.07
- Tangible Book Value Per Share
- EUR 6.08
Margins
Gross margin is 73.76%, with operating margin of -8.38%, and net profit margin of -12.83%.
- Gross Margin
- 73.76%
- Operating Margin
- -8.38%
- Pretax Margin
- -12.72%
- Net Profit Margin
- -12.83%
- EBITDA Margin
- 0.92%
- EBIT Margin
- -7.65%
Analyst Forecast
The average price target for OrthoPediatrics is EUR 27.34, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 27.34
- Price Target Upside
- 5.06% Downside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 7
- Revenue Growth Forecast
- 10.70%
- EPS Growth Forecast
- 31.31%
Scores
- Smart Score
- 8
- AI Score
- ―

